Penglin Liu
Overview
Explore the profile of Penglin Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Liu P, Yin A, Zhang B, Xu J, Chen Z, et al.
Int J Cancer
. 2025 Mar;
PMID: 40026066
Cervical cancer remains a major public health challenge worldwide, despite being largely preventable through effective interventions. Timely evidence regarding the global landscape of cervical cancer is crucial for measuring the...
2.
Deng M, Tang F, Chang X, Zhang Y, Liu P, Ji X, et al.
NPJ Precis Oncol
. 2025 Feb;
9(1):56.
PMID: 40021735
No abstract available.
3.
A targetable OSGIN1 - AMPK - SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis
Deng M, Tang F, Chang X, Zhang Y, Liu P, Ji X, et al.
NPJ Precis Oncol
. 2025 Jan;
9(1):15.
PMID: 39809873
Despite advances in various chemotherapy regimens, current therapeutic options are limited for ovarian cancer patients. Oxidative stress-induced growth inhibitor 1 (OSGIN1), which is a tumor suppressor gene known to regulate...
4.
Xu Z, Zhao G, Zhang L, Qiao C, Wang H, Wei H, et al.
J Ethnopharmacol
. 2024 Jul;
334:118541.
PMID: 38992403
Ethnopharmacological Relevance: Based on the core pathogenesis of hepatosplenic disorder and qi transformation disorder in ulcerative colitis, Tong-Xie-Yao-Fang (TXYF) is a classical traditional Chinese medicine commonly used to treat ulcerative...
5.
Liu P, Wang Y, Ji X, Kong W, Pan Z, Xu C, et al.
Front Endocrinol (Lausanne)
. 2024 Jun;
15:1371393.
PMID: 38863936
Background And Aims: The association of the triglyceride-glucose (TyG) index, a promising novel biomarker for insulin resistance, with the risk of endometriosis has not been investigated to date. This nationwide...
6.
Liu P, Ji X, Li Z, Kong W, Pan Z, Deng M, et al.
J Gynecol Oncol
. 2024 May;
35(6):e101.
PMID: 38710531
Objective: To investigate the association of primary tumor site with prognosis in vulvar cancer, stratified by vulvar squamous cell carcinoma (SCC) and non-SCC histological types. Methods: This population-based retrospective study...
7.
Deng M, Tang F, Chang X, Liu P, Ji X, Hao M, et al.
Mol Pharm
. 2024 Jan;
21(2):454-466.
PMID: 38232985
Ovarian cancer, one of the deadliest malignancies, lacks effective treatment, despite advancements in surgical techniques and chemotherapy. Thus, new therapeutic approaches are imperative to improving treatment outcomes. Immunotherapy, which has...
8.
Yu H, Liu P, Chen T
Arch Dermatol Res
. 2023 Jul;
315(9):2585-2596.
PMID: 37405427
Cutaneous squamous cell carcinoma (CSCC) is a severe malignancy derived from the skin. Circular RNAs (circRNAs) play an important role in the pathological process of many malignant tumors. Moreover, circIFFO1...
9.
Liu P, Li Z, Miao J, Kong B, Song K
Lancet Oncol
. 2023 Jun;
24(6):e237.
PMID: 37269855
No abstract available.
10.
Li Z, Liu P, Wang Z, Zhang Z, Chen Z, Chu R, et al.
Lancet Oncol
. 2023 Mar;
24(4):403-414.
PMID: 36933562
Background: Human papillomavirus (HPV) DNA and p16 positivity have crucial roles in the pathogenesis of vulvar cancer and vulvar intraepithelial neoplasia. We aimed to examine the pooled prevalence of HPV...